Journal of the Korean Ophthalmological Society 2006;47(3):489-493.
Published online March 31, 2006.
A Case Report: Treatment of Orbital Lymphangioma with Intralesional OK-432 Injection.
Jung Bum Choi, Jin Sook Yoon, Jin Young Choi, Sang Yeul Lee
1Siloam Eye Hospital, Seoul, Korea.
2The Institute of Vision Research Department of Ophthalmology, Yonsei University College of Medicine, Seoul, Korea. sylee@yumc.yonsei.ac.kr
병변 내 OK-432 주입술을 통한 안와림프관종의 치료 1예
최정범1,윤진숙2,최진영2,이상렬2
Siloam Eye Hospital1, Seoul, Korea The Institute of Vision Research Department of Ophthalmology, Yonsei University College of Medicine2, Seoul, Korea
Correspondence:  Jung Bum Choi, M.D.1
Abstract
PURPOSE
To report the first domestic case of orbital lymphangioma treated with intralesional OK-432 injection. METHODS: Initial treatment with systemic corticosteroid had failed. After aspirating the blood, we injected OK-432 (0.05 mg) into the cystic space of the orbital lymphangioma. RESULTS: Although there were minor complications, such as fever and mild tenderness, the patient had an uneventful recovery. After 6 weeks, her visual axis was restored. CONCLUSIONS: We successfully treated this infant patient with an intralesional OK-432 injection. Based on this success, we suggest that treatment of orbital lymphangioma which is refractory to conservative treatment and difficult to resect, may include an intralesional OK-432 injection.
Key Words: OK-432;Orbital lymphangioma


ABOUT
BROWSE ARTICLES
EDITORIAL POLICY
FOR CONTRIBUTORS
Editorial Office
SKY 1004 Building #701
50-1 Jungnim-ro, Jung-gu, Seoul 04508, Korea
Tel: +82-2-583-6520    Fax: +82-2-583-6521    E-mail: kos08@ophthalmology.org                

Copyright © 2023 by Korean Ophthalmological Society.

Developed in M2PI

Close layer
prev next